Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-12-19
2006-12-19
Li, Q. Janice (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S093200, C424S093210, C435S320100, C435S325000, C435S455000
Reexamination Certificate
active
07151090
ABSTRACT:
Methods are provided wherein the survival of an organ transplant is enhanced by introducing into cells of the transplant a nucleic acid molecule that modulates heme oxygenase-I activity therein. Nucleic acid molecules that modulate heme oxygenase-I activity and therefore find use in the described methods include, for example, molecules that encode a polypeptide that itself exhibits heme oxygenase-I activity or antisense oligonucleotides that act to inhibit heme oxygenase-I activity in a cell.
REFERENCES:
patent: 4829984 (1989-05-01), Gordon
patent: 5563132 (1996-10-01), Bodaness
patent: 5756492 (1998-05-01), Buelow et al.
patent: 6013641 (2000-01-01), Lussow et al.
patent: 6060467 (2000-05-01), Buelow
patent: 6861414 (2005-03-01), Buelow et al.
patent: WO 96/09038 (1996-03-01), None
patent: WO 98/09618 (1998-03-01), None
patent: WO 98/09618 (1998-03-01), None
patent: WO 99/23215 (1999-05-01), None
patent: WO 99/23215 (1999-05-01), None
patent: WO 00/12118 (2000-03-01), None
patent: WO 00/12118 (2000-03-01), None
Blydt-Hansen et al, J Am Soc Nephrol 2003;14:745-54.
Ke et al, Transplant Proceed 2002 ; 34 :1465-6.
Christine et al, Am J Transplant 2002 :2:581-92.
Braudeau et al, Gene Ther 2004 :11 :701-10.
Abraham, N.G., et al., “Retinal pigment epithelial cell-based gene therapy against hemoglobin toxicity,”Int. J. Mol. Med.1:657-663 (1998).
Abraham, N.G., et al., “The physiological significance of heme oxygenase,”Int. J. Biochem.20(6):543-558 (1988).
Agarwar, A., et al., “Gas-generating systems in acute renal allograft rejection in the rat,”Transplantation61(1):93-98 (Jan. 1996).
Alberts, B., et al., “Chapter 3: Macromolecules: Structure, Shape, and Information,”Molecular Biology of the Cell,B. Alberts et al. (eds.), 3rded., pp. 122-123, Garland Publishing, Inc.: New York, NY (1994).
Amersi, F., et al., “Carbon monoxide provides protection against ischemia/reperfusion injury in rat livers,” No. 156,Conf. Proc. Transplant 2001, The Joint American Transplant Meeting, Chicago, IL (May 11-16, 2001).
Amersi, R., et al., “Upregulation of heme oxygenase-1 protects genetically fat Zukcer rat livers from ischemia/reperfusion injury,”J. Clin. Invest.104(11): 1631-1639 (Dec. 1999).
Arhehali, A., et al., “Direct gene transfer into donor hearts at the time of harvests,”J. Thorac. Cardiovasc. Surg.109(4):716-719 (1995).
Bentz, J., et al., “DINAMO: interactive protein alignment and model building,”Bioinformatics15(4):309-316 (1999).
Blydt-Hansen, T.D., et al., “Heme oxygenase-1 gene transfer protects against ischemia/reperfusion injury in rat renal isograft model,” No. 157,Conf. Proc. Transplant 2001, The Joint American Transplant Meeting, Chicago, IL (May 11-16, 2001).
Boasquevisque, C., et al., “Ex vivoliposome-mediated gene transfer to lung isografts,”J. Thorac. Cardiovasc. Surg.115(1):38-44 (Jan. 1998).
Boucher, R., “Status of gene therapy for cystic fribrosis lung disease,”J. Clin. Invest.103(4):441-445 (Feb. 1999).
Bowie, J., et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,”Science247:1306-1310 (Mar. 1990).
Brauner, R., et al., “Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival,”J. Thorac. Cardiovasc. Surg.114(6):923-933 (Dec. 1997).
Brouard, S., et al., “Carbon monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis through a P38 mark dependent mechanism,” No. 1027,Conf. Proc. Transplant 2001, The Joint American Transplant Meeting, Chicago, IL (May 11-16, 2001).
Büeler, H., “Adeno-associated viral vectors for gene transfer and gene therapy,”Biol. Chem.380(6):613-622 (1999).
Chaveau, C., et al., “Heme oxygenase-1 (HO-1) gene transfer delayed allograft acute rejection in a rat model,” No. 36,Conf. Proc. Transplant 2001, The Joint American Transplant Meeting, Chicago, IL (May 11-16, 2001).
Coito, A., et al., “Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia/reperfusion injury,” No. 155,Conf. Proc. Transplant 2001, The Joint American Transplant Meeting, Chicago, IL (May 11-16, 2001).
Crystal, R.G., “Transfer of genes to humans: early lessons and obstacles to success,”Science270(5235):404-410 (Oct. 1995).
Cuturi, M., et al., “RDP1258, a New Rationally Designed Immunosuppressive Peptide, Prolongs Allograft Survival in Rats: Analysis of Its Mechanism of Action,”Mol. Med.5(12):820-832 (Dec. 1999).
Dean, p., et al., “Induction of heme oxygenase-1 with cobalt protoporphyrin fails to prolong hamster-to-rat kidney xenograft survival,” No. 1266,Conf. Proc. Transplant 2001, The Joint American Transplant Meeting, Chicago, IL (May 11-16, 2001).
DeBruyne, L., et al., “Gene transfer of immunomodulatory peptides correlates with heme oxygenase-1 induction and enhanced allograft survival,”Transplantation69(1):120-128 (Jan. 2000).
DeBruyne, L., et al., “Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune response,”Gene Ther.5(8):1079-1087 (Aug. 1998).
Drummond, G., et al., “Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation,”Proc. Natl. Acad. Sci. USA78(10):6466-6470 (Oct. 1981).
Eck, et al., “Chapter 5,”Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9thed., pp. 77-101, McGraw Hill: New York, NY (1995).
Evans, C-O, et al., “Cloning and sequencing and expression of cDNA for chick liver heme oxygenase: comparison of avian and mammalian cDNAs and deduced protein,”Biochem. J.273:659-666 (1991).
Haga, Y., et al., “Unconjugated bilirubin inhibitsin vitromajor histocompatibility complex-unrestricted cytotoxicity of human lymphocytes,”Biochim. Biophys. Acta1316:29-34 (1996).
Hancock, W., et al., “Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptic genes,”Nat. Med.4(12):1392-1396 (Dec. 1998).
Hegazy, K.A., et al., “Functional human heme oxygenase has a neuroprotective effect on adult rat ganglion cells after pressure induced ischemia,”NeuroReport11(6):1185-1189 (Apr. 2000).
Hori, R., et al., “Gene transfection of H25A mutant heme oxygenase-1 protects cells against hyperoxide-induced cytotoxicity,”J. Biol. Chem.277(12):10712-10718 (Mar. 2002).
Ishikawa, K., et al., “Expression of rat heme oxygenase inExcherichia colias a catalytically active, full length form that binds to bacterial membranes,”Eur. J. Biochem.202:161-165 (1991).
Iyer, S., et al., “Characterization and biological significance of immunosuppressive peptide D2702.75-84 (E → V) binding protein,”J. Biol. Chem.273(5):2692-2697 (1998).
Juan, S-H., et al., Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atheroscloerosis in apolipoprotein E-deficient mice.*Circulation104:1519-1525 (2001).
Katori, M., et al., “Heme oxygenase-1 overexpression exerts cytoprotective effects against ischemia/reperfusion injury via anti-apoptotic pathway,” No. 843,Conf. Proc. Transplant 2001, The Joint American Transplant Meeting, Chicago, IL (May 11-16, 2001).
Ke, B., et al., “Heme oxygenase-1 gene transfer prevents Fas/Fas ligand-induced apoptosisin vitroand improves allograft functionin vivo,” No. 2,Conf. Proc. Transplant 2001, The Joint American Transplant Meeting, Chicago, IL (May 11-16, 2001).
Kuemmerle, N.B., et al., “Gene expression after intrarenal injection of plasmid DNA in the rat,”Pediatr. Nephrol.14(2):152-157 (2000).
Ledley, F.D., “Pharmaceutical approach to somatic gene therapy,”Pharm. Rev.13(11
Buelow Roland
Iyer Suhasini
Woo Jacky
Dorsey & Whitney LLP
Li Q. Janice
Lorenz Todd A.
Sangstat Medical Corporation
LandOfFree
Methods for enhancing graft survival by modulating heme... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for enhancing graft survival by modulating heme..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for enhancing graft survival by modulating heme... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3701417